Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized Older Adults: A Retrospective Descriptive Study

Table 2

Prescribing patterns of olanzapine IM.

	Received olanzapine	Received no olanzapine	All prescriptions
	Indication(s) of therapy	Number (%)
Refusal/unable to take oral meds	9 (19.6%)	7 (12.5%)	16 (15.7%)
Agitation	3 (6.5%)	3 (5.3%)	6 (5.9%)
Others	2 (4.3%)	1 (1.8%)	3 (2.9%)
Combination of indications
Agitation and/or refusal/unable	12 (26.1%)	22 (39.3%)	34 (33.3%)
Agitation, refusal/unable, and/or aggression	9 (19.6%)	12 (21.4%)	21 (20.6%)
Agitation and/or aggression	4 (8.7%)	8 (14.3%)	12 (11.8%)
Psychosis and/or agitation	1 (2.2%)	2 (3.6%)	3 (2.9%)
Psychosis, agitation, and/or aggression	3 (6.5%)	0 (0.0%)	3 (2.9%)
Psychosis, agitation, and/or refusal/unable	2 (4.3%)	0 (0.0%)	2 (2.0%)
Agitation and/or others	1 (2.2%)	0 (0.0%)	1 (1.0%)
Aggression and/or refusal/unable	0 (0.0%)	1 (1.8%)	1 (1.0%)
Duration of therapy (days)
Mean ± SD	26.7 ± 39.6	14.1 ± 13.0	19.2 ± 27.80
Range	5–250	1–60	1–250